Why Is Hims & Hers Stock Soaring After FDA's Announcment?

Hims & Hers stock rises as FDA plans to ease peptide therapy rules, opening new revenue opportunities and shifting regulatory outlook. Importance Rank: 1 read more

Go to News Site